biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > $200k non-brokered raise

<< Previous

Bullboard Posts

Next >>

Comment by Finallytherockon Feb 19, 2022 11:07am

83 Views

Post# 34444821

RE:RE:RE:RE:RE:RE:RE:$200k non-brokered raise

So go to another board if you don't like it. I'm just interested to know what you talk about on other boards? There's nothing going on with this company so what's to talk about? The silence of the ceo? The fact that nothing she's said has happened? No updates on chiasi, prothena or any other partnership. No drugs in the clinic after 10+ years. No volume oj the stock. Stock trading at a 52 week low. Company mentions seeking strategic alternatives. Sounds like you have a real winner here

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China